Maricich Yuri 4

4 · Pear Therapeutics, Inc. · Filed Dec 7, 2021

Insider Transaction Report

Form 4

Period: 2021-12-03

Pear Therapeutics, Inc.PEAR

Maricich Yuri

Chief Medical Officer

Transactions

Award
Stock Option (Right to Buy)
2021-12-03+103,068→ 103,068 total
Exercise: $1.09Exp: 2030-03-24→ Common Stock (103,068 underlying)
Award
Class A Common Stock
2021-12-03+73,620→ 73,620 total
Award
Stock Option (Right to Buy)
2021-12-03+44,172→ 44,172 total
Exercise: $0.68Exp: 2027-12-13→ Common Stock (44,172 underlying)
Award
Stock Option (Right to Buy)
2021-12-03+103,068→ 103,068 total
Exercise: $0.72Exp: 2028-03-21→ Common Stock (103,068 underlying)
Award
Stock Option (Right to Buy)
2021-12-03+73,620→ 73,620 total
Exercise: $0.02Exp: 2025-05-05→ Common Stock (73,620 underlying)
Award
Stock Option (Right to Buy)
2021-12-03+176,689→ 176,689 total
Exercise: $0.14Exp: 2026-05-10→ Common Stock (176,689 underlying)
Award
Stock Option (Right to Buy)
2021-12-03+88,344→ 88,344 total
Exercise: $1.08Exp: 2029-03-14→ Common Stock (88,344 underlying)
Award
Stock Option (Right to Buy)
2021-12-03+220,862→ 220,862 total
Exercise: $1.29Exp: 2031-01-26→ Common Stock (220,862 underlying)

Footnotes (12)

[F1]Received in accordance with the terms of the Business Combination Agreement (the "Business Combination Agreement") dated as of June 21, 2021, by and among Thimble Point Acquisition Corp., Oz Merger Sub, Inc. and Pear Therapeutics (US), Inc. (f/k/a Pear Therapeutics, Inc.) ("Private Pear"), in exchange for 50,000 shares of common stock of Private Pear previously held by Mr. Maricich.
[F10]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 70,000 shares of common stock of Private Pear for $1.60 per share.
[F11]25% of the shares underlying the option vested or shall vest on January 26, 2022 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
[F12]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 150,000 shares of common stock of Private Pear for $1.89 per share.
[F2]100% of the shares subject to this option are fully vested and exercisable.
[F3]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 50,000 shares of common stock of Private Pear for $0.02 per share.
[F4]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 30,000 shares of common stock of Private Pear for $1.00 per share.
[F5]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 120,000 shares of common stock of Private Pear for $0.20 per share.
[F6]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 70,000 shares of common stock of Private Pear for $1.05 per share.
[F7]25% of the shares underlying the option vested or shall vest on March 14, 2020 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
[F8]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 60,000 shares of common stock of Private Pear for $1.58 per share.
[F9]25% of the shares underlying the option vested or shall vest on March 24, 2021 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES